Search Results

Hypothermia is a well documented problem for surgical patients and is historically addressed by the use of a variety of warming aids and devices applied to the patient before, during, and after surgery. Their effectiveness is limited in many surgeries by practical constraints of surgical access, and hypothermia remains a significant concern. Increasing the temperature of the operating room has been proposed as an alternative solution. However, operating room temperatures must be cool enough to limit thermal stress on the surgical team despite the heat transport barriers imposed by protective sterile garments. Space technology in the form of the liquid cooling garment worn by EVA astronauts answers this need. Hamilton Sundstrand Space Systems International (HSSSI) has been working with Hartford Hospital to adapt liquid cooling garment technology for use by surgical teams in order to allow them to work comfortably in warmer operating room environments.

The TIMES system was evaluated to determine its ability to process reverse osmosis (RO) brine as one of the Advanced Water Processor steps. Since preliminary testing performed in 1998 showed that the membrane typically used in the process (Nafion 117) offered a very poor ammonia rejection, a search for an alternate membrane exhibiting high ammonia rejection capability was initiated under NASA-JSC funding. This investigation has resulted in the selection of a PolyVinylAlcohol (PVA) composite membrane as a replacement. When processing RO brine and untreated human urine as feeds, the Pervap 2201 membrane showed a 96% ammonia rejection over a large range of ammonia concentration. The water permeation rates in both laboratory-scale and pilot scale testings were also similar to the Nafion. The water permeance of the Pervap 2201 was approximately 7.5 kg/h/m2/atm (1.1 lb/h/m2/psi).

Hamilton Sundstrand Space Systems International, Inc. (HSSSI) is under contract to NASA Marshall Space Flight Center (MSFC) to develop a Water Processor Assembly (WPA) for the International Space Station (ISS). The WPA produces potable quality water from humidity condensate, carbon dioxide reduction water, water obtained from fuel cells, reclaimed urine distillate, shower, handwash and oral hygiene wastewaters. All planned development testing has been completed and this paper provides the status of the development activities and results for the WPA.

The International Space Station Waste Collector Subsystem Risk Mitigation Experiment (ISS WCS RME) was flown as the primary (Shuttle) WCS on Space Shuttle flight STS-104 (ISS-7A) in July 2001, to validate new design enhancements. In general, the WCS is utilized for collecting, storing, and compacting fecal & associated personal hygiene waste, in a zero gravity environment. In addition, the WCS collects and transfers urine to the Shuttle waste storage tank. All functions are executed while controlling odors and providing crew comfort. The ISS WCS previously flew on three Shuttle flights as the Extended Duration Orbiter (EDO) WCS, as it was originally designed to support extended duration Space Shuttle flights up to 30 days in length. Soon after its third flight, the Space Shuttle Program decided to no longer require 30 day extended mission duration capability and provided the EDO WCS to the ISS Program.

The Water Processor developed for the International Space Station includes a high temperature catalytic reactor that utilizes oxygen gas to oxidize dissolved chemicals. The effluent from the reactor is a mixture of gases (O2, CO2, N2) and hot water. Since the crew has requested that drinking water does not contain any free gas at body temperature (37.8 °C or 100 °F), a phase separator operating at elevated temperatures is required downstream of the catalytic reactor. For this application, Hamilton Sundstrand Space Systems International (HSSSI) has developed a passive Gas Liquid Separator (GLS) that relies on a positive barrier - a membrane - to extract the free gas from the inlet two-phase mixture. The membrane selected is a hollow fiber hydrophobic asymmetric membrane with pore size in the ultra-filtration range. This paper outlines the challenges in both design and operation that were overcome during the development of this device.